Condition: Urgency Incontinence · Mixed Incontinence, Urge and Stress · Sponsor: Umeå University
This observational study aims to evaluate the implementation and use of the Tät®II app for the treatment of urgency and mixed urinary incontinence in women over the age of 18 after contact with ordinary healthcare, as well as its effectiveness. The study aims to answer the following question: Is treatment via the app effective and feasible after primary care? Participants will use the app for 15 weeks to treat urgency and mixed urinary incontinence. They will answer online survey questions about their urinary incontinence before, after 15 weeks, and one year after treatment.
This description comes directly from the study's public registry record.
Annelie Olofsson, MD, PhD · +46 70 54 58 116 · annelie.olofsson@umu.se
Emma Nyström, MD, PhD · emma.nystrom@umu.se
Always discuss trial participation with your own doctor first.
| Region Jämtland Härjedalen | Östersund, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07038811